ConductScience.org, home

Paper17544816

C1 inhibitor: biologic activities that are independent of protease inhibition.

Davis AE and 2 others. Immunobiology, 2007. Cited by 50 papers, by iCite.

Cite this record

ConductScience Library. C1 inhibitor: biologic activities that are independent of protease inhibition. Papers, record 17544816. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17544816

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
C1 inhibitor: biologic activities that are independent of protease inhibition.
PubMed
Journal
Immunobiology
PubMed
Year
2007
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
50
iCite
Relative citation ratio, by iCite
1.28
iCite
Revised in PubMed
2025-06-08
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Davis AE 3rdAlvin E
2Cai SShenghe
3Liu DDongxu

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Complement C1 Inhibitor ProteinMajor topic
EndopeptidasesMajor topic
Animals
Complement Activation
Endotoxins
Extracellular Matrix
Humans
Protein Binding

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AI057366NIAID NIH HHSUnited StatesR01AI057366PubMed and NIHNIH RePORTER
R37 HD022082NICHD NIH HHSUnited StatesR37HD022082PubMed and NIHNIH RePORTER

Download CSV of grants

References90

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112960171Lysines 128 and 132 enable lipopolysaccharide binding to MD-2, leading to Toll-like receptor-4 aggregation and signal transduction.J Biol Chem2003https://conductscience.org/library/papers/12960171PubMed
214586496Effects of C1 esterase inhibitor administration on intestinal functional capillary density, leukocyte adherence and mesenteric plasma extravasation during experimental endotoxemia.Intensive Care Med2004https://conductscience.org/library/papers/14586496PubMed
310917977C1 esterase inhibitor concentrate during surgery with cardiopulmonary bypass: is there an indication beyond substitution therapy in patients with hereditary angioneurotic edema?J Thorac Cardiovasc Surg2000https://conductscience.org/library/papers/10917977PubMed
412773483Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells.FASEB J2003https://conductscience.org/library/papers/12773483PubMed
510679061Cutting edge: complement-activating complex of ficolin and mannose-binding lectin-associated serine protease.J Immunol2000https://conductscience.org/library/papers/10679061PubMed
610873859A conserved structural motif for lipopolysaccharide recognition by procaryotic and eucaryotic proteins.Structure2000https://conductscience.org/library/papers/10873859PubMed
78847866Bradykinin B2 receptor involvement in rabbit and murine models of septic shock.J Cardiovasc Pharmacol1996https://conductscience.org/library/papers/8847866PubMed
88123494A pilot study to evaluate the effects of C1 esterase inhibitor on the toxicity of high-dose interleukin 2.Br J Cancer1994https://conductscience.org/library/papers/8123494PubMed
99681790Rescue therapy with C1-esterase inhibitor concentrate after emergency coronary surgery for failed PTCA.Intensive Care Med1998https://conductscience.org/library/papers/9681790PubMed
1015879149A direct role for C1 inhibitor in regulation of leukocyte adhesion.J Immunol2005https://conductscience.org/library/papers/15879149PubMed
118454352Complement component C5 modulates the systemic tumor necrosis factor response in murine endotoxic shock.Infect Immun1993https://conductscience.org/library/papers/8454352PubMed
1210199542Combined antithrombin III and C1-esterase inhibitor treatment decreases intravascular fibrin deposition and attenuates cardiorespiratory impairment in rabbits exposed to Escherichia coli endotoxin.Crit Care Med1999https://conductscience.org/library/papers/10199542PubMed
137831367Initial studies on the administration of C1-esterase inhibitor to patients with septic shock or with a vascular leak syndrome induced by interleukin-2 therapy.Prog Clin Biol Res1994https://conductscience.org/library/papers/7831367PubMed
1411505352Effect of C1-esterase-inhibitor on capillary leak and inflammatory response syndrome during arterial switch operations in neonates.J Cardiothorac Vasc Anesth2001https://conductscience.org/library/papers/11505352PubMed
1510408384C1-inhibitor attenuates hyperacute rejection and inhibits complement, leukocyte and platelet activation in an ex vivo pig-to-human perfusion model.Immunopharmacology1999https://conductscience.org/library/papers/10408384PubMed
1615111332The powerful neuroprotective action of C1-inhibitor on brain ischemia-reperfusion injury does not require C1q.Am J Pathol2004https://conductscience.org/library/papers/15111332PubMed
177529231A region of human CD14 required for lipopolysaccharide binding.J Biol Chem1995https://conductscience.org/library/papers/7529231PubMed
189024160Intracoronary application of C1 esterase inhibitor improves cardiac function and reduces myocardial necrosis in an experimental model of ischemia and reperfusion.Circulation1997https://conductscience.org/library/papers/9024160PubMed
1911737055Endothelial targeting with C1-inhibitor reduces complement activation in vitro and during ex vivo reperfusion of pig liver.Clin Exp Immunol2001https://conductscience.org/library/papers/11737055PubMed
206725552Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor.J Clin Invest1984https://conductscience.org/library/papers/6725552PubMed

See all 90 referencesDownload CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.

PMIDTitleJournalYearIn PapersSource
42729864Structure and function of therapeutic antibodies approved by the US FDA in 2025.Antib Ther2026https://conductscience.org/library/papers/42729864PubMed
41410053Therapeutic Potential of C1-Inhibitor in Vascular Diseases and Beyond.Arterioscler Thromb Vasc Biol2026https://conductscience.org/library/papers/41410053PubMed
36515245SerpinG1: A Novel Biomarker Associated With Poor Coronary Collateral in Patients With Stable Coronary Disease and Chronic Total Occlusion.J Am Heart Assoc2022https://conductscience.org/library/papers/36515245PubMed
33875620Pentraxin-3-mediated complement activation in a swine model of renal ischemia/reperfusion injury.Aging (Albany NY)2021https://conductscience.org/library/papers/33875620PubMed
31671645Meta-Analysis of Polymyositis and Dermatomyositis Microarray Data Reveals Novel Genetic Biomarkers.Genes (Basel)2019https://conductscience.org/library/papers/31671645PubMed
27338096Polyphosphate is a novel cofactor for regulation of complement by a serpin, C1 inhibitor.Blood2016https://conductscience.org/library/papers/27338096PubMed
27083187Molecular characterization of serine protease inhibitor isoform 3, SmSPI, from Schistosoma mansoni.Parasitol Res2016https://conductscience.org/library/papers/27083187PubMed
26872035Alternative Pathway Inhibition by Exogenous Factor H Fails to Attenuate Inflammation and Vascular Leakage in Experimental Pneumococcal Sepsis in Mice.PLoS One2016https://conductscience.org/library/papers/26872035PubMed
26599489Potential Roles for C1 Inhibitor in Transplantation.Transplantation2016https://conductscience.org/library/papers/26599489PubMed
26157611Bayesian phylogeny analysis of vertebrate serpins illustrates evolutionary conservation of the intron and indels based six groups classification system from lampreys for ∼500 MY.PeerJ2015https://conductscience.org/library/papers/26157611PubMed
26154504A Nationwide Study of Norwegian Patients with Hereditary Angioedema with C1 Inhibitor Deficiency Identified Six Novel Mutations in SERPING1.PLoS One2015https://conductscience.org/library/papers/26154504PubMed
25773165Growth factors and IL-17 in hereditary angioedema.Clin Exp Med2016https://conductscience.org/library/papers/25773165PubMed
25403109Potential role of the lectin pathway of complement in the pathogenesis and disease manifestations of systemic sclerosis: a case-control and cohort study.Arthritis Res Ther2014https://conductscience.org/library/papers/25403109PubMed
24386641Impact of mannose-binding lectin deficiency on radiocontrast-induced renal dysfunction.Biomed Res Int2013https://conductscience.org/library/papers/24386641PubMed
23607270C1-inhibitor efficiently inhibits Escherichia coli-induced tissue factor mRNA up-regulation, monocyte tissue factor expression and coagulation activation in human whole blood.Clin Exp Immunol2013https://conductscience.org/library/papers/23607270PubMed
23483208Hepatitis B virus X protein modulates apoptosis in human renal proximal tubular epithelial cells by activating the JAK2/STAT3 signaling pathway.Int J Mol Med2013https://conductscience.org/library/papers/23483208PubMed
22146452Mannose-binding lectin-the forgotten molecule?Nat Med2011https://conductscience.org/library/papers/22146452PubMed
21345278Bench-to-bedside review: the role of C1-esterase inhibitor in sepsis and other critical illnesses.Crit Care2011https://conductscience.org/library/papers/21345278PubMed
21090636Utilizing spectral counting to quantitatively characterize tandem removal of abundant proteins (TRAP) in human plasma.Anal Chem2010https://conductscience.org/library/papers/21090636PubMed
19961953The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited.Prog Retin Eye Res2010https://conductscience.org/library/papers/19961953PubMed

Download CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CFH3075PubTator's text mininghttps://conductscience.org/library/genes/3075NCBI Gene
ERVK-3100862689PubTator's text mininghttps://conductscience.org/library/genes/100862689NCBI Gene
FGB2244PubTator's text mininghttps://conductscience.org/library/genes/2244NCBI Gene
NID14811PubTator's text mininghttps://conductscience.org/library/genes/4811NCBI Gene
SELE6401PubTator's text mininghttps://conductscience.org/library/genes/6401NCBI Gene
SELP6403PubTator's text mininghttps://conductscience.org/library/genes/6403NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17544816

GET https://conductscience.org/api/papers/v1/17544816/references?page=2